KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Operating income, 2025
- $161M
- YoY, 2025
- +145.3%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $161M | +145.3% |
| 2024 | $66M | — |
| 2023 | −$110M | — |
| 2022 | −$145M | — |
| 2021 | −$68M | — |
| 2020 | −$33M | — |
| 2019 | −$22M | — |
| 2018 | −$12M | — |
| 2017 | −$4.8M | — |
| 2016 | −$1.1M | — |